Pregled bibliografske jedinice broj: 1160191
Integration of cardiovascular risk assessment with COVID-19 using artificial intelligence
Integration of cardiovascular risk assessment with COVID-19 using artificial intelligence // Reviews in cardiovascular medicine, 21 (2020), 4; 541-560 doi:10.31083/j.rcm.2020.04.236 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1160191 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Integration of cardiovascular risk assessment with COVID-19 using artificial intelligence
Autori
Suri, Jasjit S. ; Puvvula, Anudeep ; Majhail, Misha ; Biswas, Mainak ; Jamthikar, Ankush D. ; Saba, Luca ; Faa, Gavino ; Singh, Inder M. ; Oberleitner, Ronald ; Turk, Monika ; Srivastava, Saurabh ; Chadha, Paramjit S. ; Suri, Harman S. ; Johri, Amer M. ; Nambi, Vijay ; Sanches, J. Miguel ; Khanna, Narendra N. ; Viskovic, Klaudija ; Mavrogeni, Sophie ; Laird, John R. ; Bit, Arindam ; Pareek, Gyan ; Miner, Martin ; Balestrieri, Antonella ; Sfikakis, Petros P. ; Tsoulfas, George ; Protogerou, Athanasios ; Misra, Durga Prasanna ; Agarwal, Vikas ; Kitas, George D. ; Kolluri, Raghu ; Teji, Jagjit ; Porcu, Michele ; Al-Maini, Mustafa ; Agbakoba, Ann ; Sockalingam, Meyypan ; Sexena, Ajit ; Nicolaides, Andrew ; Sharma, Aditya ; Rathore, Vijay ; Viswanathan, Vijay ; Naidu, Subbaram ; Bhatt, Deepak L.
Izvornik
Reviews in cardiovascular medicine (1530-6550) 21
(2020), 4;
541-560
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
COVID-19 ; cardiovascular ; myocarditis ; artificial intelligence ; risk assessment ; non-invasive monitoring
Sažetak
Artificial Intelligence (AI), in general, refers to the machines (or computers) that mimic "cognitive" functions that we associate with our mind, such as "learning" and "solving problem". New biomarkers derived from medical imaging are being discovered and are then fused with non- imaging biomarkers (such as office, laboratory, physiological, genetic, epidemiological, and clinical-based biomarkers) in a big data framework, to develop AI systems. These systems can support risk prediction and monitoring. This perspective narrative shows the powerful methods of AI for tracking cardiovascular risks. We conclude that AI could potentially become an integral part of the COVID-19 disease management system. Countries, large and small, should join hands with the WHO in building biobanks for scientists around the world to build AIbased platforms for tracking the cardiovascular risk assessment during COVID-19 times and long-term follow-up of the survivors.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinika za infektivne bolesti "Dr Fran Mihaljević",
Zdravstveno veleučilište, Zagreb,
Fakultet zdravstvenih studija u Rijeci
Profili:
Klaudija Višković
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE